Monitoring Indicators (normal range) camrelizumab+endostatin camrelizumab+bevacizumaab+endostatin Camrelizumab+bevacizumab
2021/9/2 2021/12/15 2022/3/30 2022/5/2 2022/7/15 2022/3/15 2023/11/28
TG(Triglycerides) mmol/L, (0-1.7 mmol/L) 0.95 3.1 2.87 4.35 2.64 3.88 4.52
TC(Total Cholesterol) mmol/L, (2.85-5.69 mmol/L) 6.15 5.31 5.37 6.06 5.08 5.15 5.08
AST/ALT (Aspartate Transaminase/Alanine transaminase) (0.8-1.5) 1.8 2.1 1.9 2.7 1.8 1.95 2.12